image
Healthcare - Biotechnology - NASDAQ - US
$ 0.0836
10.8 %
$ 1.44 M
Market Cap
-0.01
P/E
BALANCE SHEET
3.65 M ASSETS
-50.09%
26.9 M LIABILITIES
41.09%
-23.2 M EQUITY
-97.93%
BALANCE SHEET DECOMPOSITION
Balance Sheet NRx Pharmaceuticals, Inc.
image
Current Assets 3.3 M
Cash & Short-Term Investments 1.44 M
Receivables 0
Other Current Assets 1.86 M
Non-Current Assets 349 K
Long-Term Investments 0
PP&E 0
Other Non-Current Assets 349 K
39.52 %50.92 %9.56 %Total Assets$3.7m
Current Liabilities 21.9 M
Accounts Payable 4.13 M
Short-Term Debt 1.57 M
Other Current Liabilities 16.2 M
Non-Current Liabilities 5.01 M
Long-Term Debt 5.01 M
Other Non-Current Liabilities 0
15.37 %5.83 %60.16 %18.65 %Total Liabilities$26.9m

Balance Sheet

Millions
Dec-2024 Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017
ASSETS
Cash & Cash Equivalents 1.4 4.6 20.1 27.6 1.9 6 11.1 K 0.4
Short Term Investments 0 0 0 0 6.0 32.0 70.8 69.0
Receivables 0 6 K 0 0 0.8 0 0 0
Inventory 0 0 7 K 0 0.2 0 0 0
Other Current Assets 0 2.3 11.5 5.1 0.2 69.5 K 19.1 K 87 K
Total Current Assets 3.3 6.9 25.8 32.7 2.9 69.5 K 30.2 K 0.5
PP&E 0 0 0 0 0 0 0 0
Intangible Assets 0 0 0 0 0 0 0 0
Goodwill 0 0 0 0 0 0 0 0
Long Term Investments 0 0 0 0 0 32.0 70.8 69.0
Other Long Term Assets 0.3 0.4 21 K 15 K 11 K 1 0 0
Other Assets 0 0 0 0 0 0 0 0
Total Assets 3.7 7.3 25.8 32.7 2.9 32.1 70.8 69.6
LIABILITIES
Accounts Payable 4.1 4.6 2.1 3.7 3.2 0.6 0.6 85.7 K
Short Term Debt 1.6 9.2 7.7 0.5 0.2 0 0 0
Other Current Liabilities 16.2 5.3 5.8 7.7 42.7 69.5 K 0 7.5 K
Total Current Liabilities 21.9 19.0 16.6 11.9 46.2 0.6 0.6 93.2 K
Long Term Debt 5.0 0 2.8 0 0.5 2.0 0.7 0
Deferred Tax Income 0 0 0 0 0 0 0 0
Other Liabilities 0 0 0 0 0 0 0 0
Total Liabilities 26.9 19.0 18.4 11.9 46.7 2.6 1.3 93.2 K
EQUITY
Common Stock 15 K 84 K 67 K 59 K 43 K 24.5 64.5 64.5
Retained Earnings (278.3) (253.1) (223.1) (183.2) (90.2) 0.4 38.9 K (0.1)
Other Accumulative Comprehensive Income/Loss 0 3 K 0 0 0 (24.5) 0 0
Total Equity (23.2) (11.7) 7.4 20.8 (43.8) 29.5 69.5 69.5
Total Liabilities and Equity 3.7 7.3 25.8 32.7 2.9 32.1 70.8 69.6
SHARES OUTSTANDING
Common Shares Outstanding 10.5 7.6 65.8 46.9 34.3 0.5 0.9 0.9